While most E. coli bacteria are harmless and common, there are some that can make people sick, even leading to serious health conditions that can be fatal.
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...